Literature DB >> 12403989

Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders.

Emmanuel Mignot1, Shahrad Taheri, Seiji Nishino.   

Abstract

Delineating the basic mechanisms that regulate sleep will likely result in the development of better treatments for sleep disorders. The hypothalamus is now recognized as a key center for sleep regulation, with hypothalamic neurotransmitter systems providing the framework for therapeutic advances. An increased awareness of the close interaction between sleep and homeostatic systems is also emerging. Progress has occurred in the understanding of narcolepsy--molecular techniques have identified the lateral hypothalamic hypocretin (orexin) neuropeptide system as key to the disorder. Other sleep disorders are now being tackled in the same way and are likely to yield to efforts combining basic and clinical research. Here we highlight the role of the hypothalamus in sleep physiology and discuss neurotransmitter systems, such as adenosine, dopamine, GABA, histamine and hypocretin, that may have therapeutic applications for sleep disorders.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12403989     DOI: 10.1038/nn944

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  72 in total

1.  [The neurotransmitter, hypocretin. An overview].

Authors:  C Baumann; C Bassetti
Journal:  Nervenarzt       Date:  2004-04       Impact factor: 1.214

2.  The orexin/hypocretin system in zebrafish is connected to the aminergic and cholinergic systems.

Authors:  Jan Kaslin; Johanna M Nystedt; Maria Ostergård; Nina Peitsaro; Pertti Panula
Journal:  J Neurosci       Date:  2004-03-17       Impact factor: 6.167

Review 3.  What is the role of brain mechanisms underlying arousal in recovery of motor function after structural brain injuries?

Authors:  Andrew M Goldfine; Nicholas D Schiff
Journal:  Curr Opin Neurol       Date:  2011-12       Impact factor: 5.710

Review 4.  Clinical and diagnostic aspects of encephalopathy associated with autoimmune thyroid disease (or Hashimoto's encephalopathy).

Authors:  Gianluca Tamagno; Giovanni Federspil; Giovanni Murialdo
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

Review 5.  Sleep disorders in children and adolescents.

Authors:  Suresh Kotagal; Paul Pianosi
Journal:  BMJ       Date:  2006-04-08

Review 6.  K+ channels stimulated by glucose: a new energy-sensing pathway.

Authors:  Denis Burdakov
Journal:  Pflugers Arch       Date:  2007-01-06       Impact factor: 3.657

Review 7.  Drugs for sleep disorders: mechanisms and therapeutic prospects.

Authors:  Elemer Szabadi
Journal:  Br J Clin Pharmacol       Date:  2006-06       Impact factor: 4.335

Review 8.  Pontine reticular formation (PnO) administration of hypocretin-1 increases PnO GABA levels and wakefulness.

Authors:  Christopher J Watson; Haideliza Soto-Calderon; Ralph Lydic; Helen A Baghdoyan
Journal:  Sleep       Date:  2008-04       Impact factor: 5.849

9.  The effect of clomipramine on wake/sleep and orexinergic expression in rats.

Authors:  P Feng; Y Hu; D Li; D Vurbic; H Fan; S Wang; K P Strohl
Journal:  J Psychopharmacol       Date:  2008-06-18       Impact factor: 4.153

10.  Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice.

Authors:  Michihiro Mieda; Jon T Willie; Junko Hara; Christopher M Sinton; Takeshi Sakurai; Masashi Yanagisawa
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.